Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial
about
Nucleostemin mRNA is expressed in both normal and malignant renal tissuesModulation of neutrophil oxidative burst via histamine receptorsNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyImmunotherapy for metastatic renal cell carcinoma.Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand.Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancerHistamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma.Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.Preoperative Lymphocyte-Monocyte Ratio Ameliorates the Accuracy of Differential Diagnosis in Non-Metastatic Infiltrative Renal Masses.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Histamine: an undercover agent in multiple rare diseases?Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.Effect of Aegle marmelos leaf extract on N-methyl N-nitrosourea-induced hepatocarcinogensis in Balb/c mice.Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes.Modulation of hepatocarcinogenesis in N-methyl-N-nitrosourea treated Balb/c mice by mushroom extracts.Redox control of cancer cell destruction.Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
P2860
Q24651568-A4E94932-3416-4301-8A60-2FC87011F267Q26998785-334DC40C-9106-42A0-B299-E666EFE9DDBFQ28069360-0691B413-0E2D-460C-AA4A-5E4F8DD97F06Q30234458-34684AF2-B3FA-4FC1-8434-79375737148CQ34249083-8F7C86C0-30AD-4F32-97EE-67C7ADEA2BCAQ36896309-20280B7E-848C-45F2-9112-817E6E096C3BQ37136992-F7B3FCBB-83A5-4D52-B845-240F03C3A898Q37571981-B8328CD3-870F-47BC-90EB-BA176A1C10D1Q37622164-B5F05F25-0E1B-4101-9DDA-0A99D5963248Q37810123-63415736-5EB8-472A-904D-651EE79D66BDQ37995651-5B765C34-5D2C-4D4E-BF3C-74D33F5E639CQ38153283-18582BA8-6C8B-4530-A97C-E71A49FD4389Q39125753-85322868-0E82-4C01-8554-8C91523237FEQ44789980-FC7F1C1E-F115-49B5-B6B2-0FAFC178974CQ50848182-8CD51B67-3ACD-44E6-A01E-263D1419FCDEQ51748168-CCB800CF-43ED-48E5-B179-5BA3B04D6129Q53251663-F4A85E8A-33E7-474E-98F7-9E39F1339ADFQ53281128-8F444A5B-4898-4332-8FAA-A84D5F5081D7
P2860
Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trial
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@ast
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@en
type
label
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@ast
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@en
prefLabel
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@ast
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@en
P2093
P2860
P356
P1476
Monocytes and neutrophils as ' ...... om a randomised phase II trial
@en
P2093
H H Torp Madsen
H von der Maase
N Marcussen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602937
P407
P577
2006-01-01T00:00:00Z